You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
22 April 2026 - Biotherapeutics company PureTech Health plc reported on Wednesday that its founded entity Gallop Oncology reported positive topline Phase 1b data for LYT-200 in relapsed/refractory high-risk myelodysplastic syndrome (MDS) and acute my...
22 April 2026 -
Precision medicine company Natera Inc (NASDAQ: NTRA) on Wednesday announced the presentation of new clinical evidence supporting its Prospera test across 17 abstracts, including six ...
22 April 2026 - Healthcare products company Johnson & Johnson (NYSE:JNJ) announced on Wednesday that it has received European CE Mark approval for the ETHICON 4000 Stapler, designed to deliver consistent staple line integrity across varying tissu...
22 April 2026 - Biopharmaceutical company Solvonis Therapeutics plc (LSE: SVNS) announced on Wednesday that it has appointed US-based research and investor engagement firm Water Tower Research LLC to enhance its understanding of the US market, refine...
22 April 2026 - Ondine Biomedical Inc (LON: OBI), a provider of photodisinfection-based therapies, announced on Wednesday that it has secured acceptance of two abstracts for poster presentation at the World Congress on Infectious Diseases, taking pla...
22 April 2026 - Precision medicine diagnostics company Renalytix plc (LSE: RENX) (OTCQB: RNLXY) revealed on Wednesday that it has completed key regulatory and operational milestones to support the scaling of its kidneyintelX.dkd diagnostic platform, ...
22 April 2026 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) announced on Wednesday that the US Food and Drug Administration (FDA) has extended by up to three months the target action date for its review of the Biologics Li...